More tools:Markets·Screener·Research·Chat

ResMed Inc. (RMD) Financial Statements

ResMed Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SBGRC2
XNYS · usd
221.05▲ 0.00 (0.00%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close221.05
Day's Range220.45 – 226.67
52-Week Range180.27 – 285.80
Volume1.2M
Avg Volume1.4M
Share Statistics
Shares Outstanding
Employees10.6K
ExchangeXNYS
Listed1995-06-02
Share count as of August 10, 2026
Loading Income Statement…
Key questions about ResMed Inc. (RMD)
What is ResMed Inc.'s Market Cap?
ResMed Inc.'s Market Cap is $31.9B, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s Enterprise Value?
ResMed Inc.'s Enterprise Value is $30.8B, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s Trailing P/E?
ResMed Inc.'s Trailing P/E is 20.9×, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s Price / Sales?
ResMed Inc.'s Price / Sales is 5.6×, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s EV / Revenue?
ResMed Inc.'s EV / Revenue is 5.5×, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s EV / EBITDA?
ResMed Inc.'s EV / EBITDA is 14.8×, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s Revenue (TTM)?
ResMed Inc.'s Revenue (TTM) is $5.7B, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s Net Income (TTM)?
ResMed Inc.'s Net Income (TTM) is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s EBITDA?
ResMed Inc.'s EBITDA is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is ResMed Inc.'s Diluted EPS (TTM)?
ResMed Inc.'s Diluted EPS (TTM) is 10.56, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net revenue
YoY growth+8.6%+10.8%+11.0%+9.1%
Cost of sales (exclusive of amortization shown separately below)
Amortization of acquired intangible assets
Total cost of sales
Gross profit
% of revenue58.8%62.2%61.8%61.5%
Operating Expenses
Research and development
Selling, general, and administrative
Amortization of acquired intangible assets
Restructuring expenses (note 17)
Total operating expenses
% of revenue28.2%27.3%27.2%28.0%
Income from operations
% of revenue30.7%34.9%34.6%33.4%
Other income (loss), net:
Interest income (expense), net
Gain (loss) attributable to equity method investments (note 6)
Gain (loss) on equity investments (note 6)
Other, net
Total other income (loss), net
Income before income taxes
Income taxes (note 12)
Net income
% of revenue26.2%27.9%27.6%26.1%
Basic earnings per share (note 11) (in dollars per share)
Diluted earnings per share (note 11) (in dollars per share)